|
发表于 2022-10-26 17:53:42
|
显示全部楼层
Indeed, the largest of these trials, the NSABP B 14 extension study, randomly assigned more than 1, 100 patients in remission after 5 years of tamoxifen to either a further 5 years of tamoxifen or placebo, and actually showed a significant adverse effect for those continuing tamoxifen <a href=http://stromectol.autos/>ivermectin pour on</a> PMID 19711011 |
|